cough. Cough
Conditions
Interventions
Intervention 1: Intervention group 1: group receiving a low dose of syrup containing Pistacia atlantica oleoresin. Intervention 2: Intervention group 2: the group receiving a medium dose of syrup cont
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Suffering from subacute (3 to 8 weeks) cough Suffering from chronic (more than 8 weeks) cough
Exclusion criteria
Exclusion criteria: Taking other antitussive drugs Use of opioids Taking sedatives Taking antihistamines Taking antibiotic drugs Use of bronchodilators History of asthma History of chronic bronchitis Getting pneumonia Pulmonary abscess or pulmonary tuberculosis smokers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of coughing attacks per day. Timepoint: Fourth and seventh day. Method of measurement: Interview/questionnaire.;Number of coughs per attack. Timepoint: Fourth and seventh day. Method of measurement: Number of coughs per attack.;Checking the quality of cough. In each examination, the level of recovery is complete recovery (complete cessation of cough), partial recovery (the patient expresses satisfaction with the reduction of cough or the duration of cough is halved), no recovery (the medicine does not cause any change in the severity of cough). Timepoint: Fourth and seventh day. Method of measurement: Number of coughs per attack. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Rashidipour
Khoram-Abad University of Medical Sciences
Outcome results
None listed